Meta-analysis of randomised trials in adults with depressive-anxiety disorders: AI-enabled personalised treatment planning reduced depressive symptoms (g −0.35; 7 trials, n=757) but not anxiety (g −0.08; 7 trials, n=875) vs controls; response/remission favoured AI (OR ≈1.42).
Meta-analysis
Yıldız et al. Randomized evidence on AI-enabled personalized treatment planning for adults with depressive-anxiety Spectrum disorders: A systematic review and Meta-analysis